Loading...
research article
Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: two-year results of 2 randomized clinical trials - TAP report 2
Bressler, N. M.
To report 24-month vision and fluorescein angiographic outcomes from trials evaluating photodynamic therapy with verteporfin (Visudyne; CIBA Vision Corp, Duluth, Ga) in patients with subfoveal choroidal neovascularization (CNV) caused by age-related macular degeneration (AMD).
Type
research article
Authors
Bressler, N. M.
Publication date
2001
Publisher
Published in
Volume
119
Issue
2
Start page
198
End page
207
Subjects
Peer reviewed
REVIEWED
Written at
EPFL
Available on Infoscience
February 16, 2011
Use this identifier to reference this record